A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

17 Feb 20264 min read0 viewsOBSERVATIONAL Trial

GIST

RECRUITING · OBSERVATIONAL · Myasthenia Gravis · Enrollment 680 · Sponsor: argenx

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Infectious Disease on 17 Feb 2026. The item focuses on A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa. Open the detail page to review the full original feed content.